All 156 subjects who received trial treatment were included in the analyses
It should be noted that postmarketing reports of MTC have occurred with other GLP-1 receptor agonists (such as liraglutide), though causality has not been established
However, they can cause side effects such as diarrhea, nausea, vomiting, dizziness, and headaches and many patients quickly regain much of the weight they have lost after they stop taking the medication
AOD-9604 is a synthetic peptide made from a small part of growth hormone
Canadian Access and Considerations Canadians face a unique regulatory landscape when considering BPC-157 for research purposes
Weight Loss and Appetite Control : GLP-1 S plays a vital role in reducing appetite and promoting satiety , making it an important compound for studies into obesity and weight management therapies